Johnson & Johnson News

Johnson & Johnson | 8-K: Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization

May 1 07:04 ET

Johnson & Johnson | 8-K: Amended and Restated By-Laws and Poll Results of 2024 Stockholders Meeting

Apr 29 16:38 ET

Johnson & Johnson | 8-K/A: Johnson & Johnson Reports Q1 2024 Results (Amendment)

Apr 16 12:20 ET

Johnson & Johnson | 8-K: Johnson & Johnson Reports Q1 2024 Results and Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%

Apr 16 07:10 ET

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Apr 5 17:32 ET

Johnson & Johnson | DEFA14A: Others

Mar 13 07:43 ET

Johnson & Johnson | DEFA14A: Others

Mar 13 07:38 ET

Johnson & Johnson | DEF 14A: Definitive information statements

Mar 13 07:38 ET

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Feb 15 17:28 ET

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 29 16:55 ET

Johnson & Johnson | 8-K: Johnson & Johnson Reports Q4 and Full-Year 2023 Results

Jan 23 00:00 ET

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 9 00:00 ET

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 8 00:00 ET

Johnson & Johnson | DEFA14A: Others

Jan 8 00:00 ET

Johnson & Johnson | 8-K: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors

Dec 5, 2023 16:42 ET

Johnson & Johnson | 8-K: Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review

Dec 5, 2023 07:52 ET

Johnson & Johnson | 8-K: Johnson & Johnson MedTech Acquires Laminar, Inc.

Nov 30, 2023 16:30 ET

Johnson & Johnson | 8-K: Johnson & Johnson Deferred Compensation Plan

Nov 27, 2023 16:56 ET

Johnson & Johnson | 8-K: Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

Oct 23, 2023 16:48 ET

Johnson & Johnson | 8-K: Current report

Oct 17, 2023 07:33 ET